Newsfeeds Archive - Spark Newswire

3 minute read

Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon

June 4, 1:45 PM

On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial. On Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE:

MRK

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

June 4, 8:06 AM

Gainers Annexon (NASDAQ:ANNX) shares increased by 57.2% to $7.2 during Tuesday’s pre-market session. The market value of their…

ANL

1 minute read

Mainz Biomed Presents New Study Data For ColoFuture And eAArly DETECT Study Performance With Sensitivity For CRC Of 92% And 82% For Advanced Adenomas, Including 95.8% Detection Of High-Grade Dysplasia

By Benzinga Newsdesk

June 3, 8:16 AM

New study data confirmed previous ColoFuture and eAArly DETECT study performance with sensitivity for CRC of 92% and 82% for advanced adenomas, including 95.8% detection of high-grade dysplasia Results from pooled

MYNZ

3 minute read

Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

May 29, 8:07 AM

Shares of Ooma, Inc. (NYSE:OOMA) rose sharply in today’s pre-market trading after the company reported better-than-expected first-quarter financial…

AAL

3 minute read

Penny Stocks

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe’s Pharma Game

By Upwallstreet

May 16, 8:51 AM

On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, just ahead of this year’s “Choose Franc

ABB

3 minute read

Penny Stocks

mRNA Is Promising A Breakthrough In Fighting Cancer

By Upwallstreet

April 29, 10:02 AM

When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as it allowed pharmaceutical companies like Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ:

MRNA

3 minute read

Penny Stocks

The Pharmaceutical Industry Finds Itself At A Historical Crossroads

By Upwallstreet

April 10, 10:47 AM

Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE:

BMY

3 minute read

Pharma’s Post-Pandemic Story To Unlock A Cancer-Free Era

By Upwallstreet

April 2, 10:17 AM

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) did not only earn billions of dollars from their COVID-19 leading products but also rose to fame for saving the world from an unforeseen pandemic.

MRNA

2 minute read

2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front

By Upwallstreet

February 7, 11:13 AM

On Thursday, Merck & Co Inc (NYSE: MRK) topped estimates with its fourth quarter revenue and adjusted earnings fueled by its blockbuster cancer drug Keytruda, along with HPV prevention vaccine Gardasil. However, Merck still recorded a net quarterly loss due to charges that resulted from a

MRK

4 minute read

Penny Stocks

Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle

By Upwallstreet

February 1, 3:17 PM

On Tuesday, Pfizer Inc (NYSE: PFE) reported mixed results for its fourth quarter. Last year, Pfizer has responded to concerns related to its COVID-19 products being the rearview mirror with a cost-cutting program, internal restructuring and by getting deeper into oncology with its purchase of cancer drugmaker Seagen.

MRK